Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Neuroendocrine Tumors
Clinical trial register · United States · industry-sponsored

Neuroendocrine Tumors Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9129 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 03 Nov 2026, 03:16 UTC
9129
Studies in scope
industry-sponsored, all four open statuses
4971
Recruiting now
open to new participants
2191
Lead sponsors
across recruiting studies
Top states
Arizona 5 California 5 Florida 5 Georgia 3 Kentucky 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Neuroendocrine Tumors trials in the USA

9 of 9129 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
NCT07165132GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors
RayzeBio, Inc.
Phase 1
104
Arizona, Florida, Iowa, Kentucky, Minnesota, Missouri, Ohio, Oregon
2025-12-03
Active, closed
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
NCT07129252SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors, Neuroendocrine Neoplasm
Crinetics Pharmaceuticals Inc.
Phase 1/2
150
Arizona, California, Colorado, Connecticut, Georgia, Kentucky, Louisiana, Michigan
2025-11-26
Active, closed
Chimeric Therapeutics
Phase 1/2
135
Georgia, Illinois, Pennsylvania, Tennessee
2024-05-15
Active, closed
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
NCT05477576GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors
RayzeBio, Inc.
Phase 3
343
Arizona, California, Connecticut, District of Columbia, Florida, Georgia, Iowa, Kentucky
2022-03-24
Active, closed
Orano Med LLC
Phase 2
69
Colorado, Florida, Louisiana, Texas
2021-12-21
Active, closed
ITM Solucin GmbH
Phase 3
259
California, Colorado, Florida, Massachusetts, Minnesota, Missouri, New York, North Carolina
2021-12-21
Active, closed
Advanced Accelerator Applications
Observational
1,014
Arizona, Ohio, Oregon, Washington
2018-11-28
Active, closed
ITM Solucin GmbH
Phase 3
324
Arizona, California, Florida, Illinois, Michigan, Texas
2017-02-02
Recruiting
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
NCT02174549Hepatocellular Carcinoma, Gastrointestinal Cancer Metastatic, Neuroendocrine Tumors
Teclison Ltd.
Phase 1/2
25
California, Pennsylvania
2014-09
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 3 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/neuroendocrine-tumors

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,129 studies in total at the last sync on 03 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies listing the condition Neuroendocrine Tumors.

How many Neuroendocrine Tumors trials are recruiting in the US?

2 of the 9 studies on this page are recruiting new participants as of the 03 Nov 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Neuroendocrine Tumors), 9 studies
PhaseStudiesRecruitingShare
Phase 1/23133.3%
Phase 33033.3%
Observational1011.1%
Phase 11111.1%
Phase 21011.1%

Most active sponsors

Lead sponsors with the most studies (Neuroendocrine Tumors)
Lead sponsorStudiesRecruiting
ITM Solucin GmbH20
RayzeBio, Inc.21
Advanced Accelerator Applications10
Chimeric Therapeutics10
Crinetics Pharmaceuticals Inc.10
Orano Med LLC10
Teclison Ltd.11

Top states

Top states (Neuroendocrine Tumors), by number of studies with a site there
StateStudies
Arizona5
California5
Florida5
Colorado3
Georgia3
Kentucky3
Connecticut2
Illinois2
Iowa2
Louisiana2
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.